Institutional Biosafety Committee (IBC)

 The Institutional Biosafety Committee (IBC) is the administrative and decision-making body having responsibility for review and approval of research involving recombinant DNA.  Before any research involving recombinant DNA can be initiated it must have received IBC review and approval.  The activities of the IBC are administered by the Office of Research Compliance (ORC).


NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules ("NIH Guidelines")

Biosafety Guidance

Institutional Biosafety Committee Guidance

IBC Forms for Download

BGSU IBC Guidelines 
IBC Application Form (Revised April, 2020)
IBC Continuing Review Form (Revised April, 2020)
Biosafety Level 1 Requirements
Biosafety Level 2 Requirements

Who can I contact if I have a question about research involving recombinant DNA?

Jenifer Baranski


Mark Fox, IBC Chair


Updated: 03/15/2022 10:02AM